Cancer Prevention News

Using tests for HPV types 16 and 18 as a second triage after high-risk HPV tests in women with minor abnormal cytology may help determine whether colposcopy is necessary, according to findings published in Annals of Internal Medicine.

Cancers associated with tobacco use make up 40% of all United States cancer diagnoses, and tobacco use remains the leading preventable cause of cancer and cancer deaths in the United States, according to a recent CDC Vital Signs report.

Specialized surveillance of patients at high risk for melanoma may be more cost-effective and lead to fewer invasive procedures than the standard of care in Australia, according to a study published in Journal of Clinical Oncology.

PSA ordering and referral practices have not significantly changed since the U.S. Preventive Services Task Force issued recommendations against the routine use of PSA screening in asymptomatic men, according to a study published in Cancer.

The CDC’s Advisory Committee on Immunization Practices is recommending younger adolescents aged 11 to 12 years receive only two doses of HPV vaccine six months or more apart for preventive purposes against viral-causing cancers and infections.

Approximately one in eight women in the U.S. will develop breast cancer during their lifetime, according to the National Cancer Institute. Breast cancer risk can be reduced by regular screenings and various prevention strategies.

The routine use of screening mammography has resulted in the increased diagnosis of small breast tumors and a decreasing incidence in large tumors, according to observational study results published in The New England Journal of Medicine.

The National Committee for Quality Assurance has updated its Healthcare Effectiveness Data and Information Set quality measures for colorectal cancer screening in response to the U.S. Preventive Service Task Force guidelines, which supported viable alternatives to colonoscopy in an effort to increase flatlining screening rates.

Given equal participation rates, fecal immunochemical tests and colonoscopy are more effective and less expensive than multitarget stool DNA tests for average-risk colorectal cancer screening, according to the results of a simulation study.

Partial HPV vaccination has resulted in population-level decreases in cervical intraepithelial neoplasia, according to research published in JAMA Oncology.